Back to Directory
XapHe
Northern Ireland
Founded 2024
Targeted nanoparticle formulations for nucleic acid delivery
XapHe is a biotechnology company developing peptide-based nanoparticles for therapeutic nucleic acid delivery.
Its HAWC platform packages RNA and DNA payloads into formulations designed for cell entry and tissue targeting. The company supplies transfection kits and offers custom nanoparticle formulation services for mRNA, microRNA, oligonucleotides and gene-editing components.
Its research partnerships investigate applications in wound repair, vaccines and ocular diseases, while its delivery technology remains under development for therapeutic use.